Exocrine Pancreatic Insufficiency - 27 Studies Found

Completed : Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency
: Pancreatic Insufficiency
: 2009-11-11
:
  • Dietary Supplement: Norzyme - Bergamo

Completed : Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)
:
  • Cystic Fibrosis
  • Exocrine Pancreatic Insufficiency

: 2006-12-04
:
  • Drug: Ultrase® MT20 Ultra
Completed : A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI
:
  • Diabetes Mellitus, Type 2
  • Exocrine Pancreatic Insufficiency : 2015-02-24
    :
    • Drug: Epanova® (omega-3 carboxylic acids)

Completed : A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age
:
  • Cystic Fibrosis
  • Exocrine Pancreatic Insufficiency

: 2010-03-31
:
  • Drug: EUR-1008 (APT-1008) EUR-
Completed : PR-018: An Open-Label, Safety Extension of Study PR-011
:
  • Cystic Fibrosis
  • Exocrine Pancreatic Insufficiency

: 2010-05-25
: Drug: EUR-1008 (APT-1008) EUR-1008 (APT-1008) (Zenpep® [pancrelipase] 3,000 lipase units delayed re
RECRUITING : Phase 1 Study to Assess Safety and Efficacy of ANG003
: Exocrine Pancreatic Insufficiency
: 2024-11-21
: To evaluate four possible combinations of lipase, protease and amylase.
RECRUITING : Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis
: Exocrine Pancreatic Insufficiency
: 2024-11-21
: Enteric microgranule formulation of adrulipase.
<<< Previous